Effects of eating nuts on obese diabetic women

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the impact of acute walnut consumption on inflammatory responses and oxidative stress in obese women with type 2 diabetes. It aims to understand how walnuts may help mitigate the negative health effects associated with high saturated fat meals, which are linked to obesity and diabetes. Participants will consume nuts during two separate meetings, and their metabolic responses will be monitored to assess the potential benefits of walnut intake. The research focuses on the relationship between diet, obesity, and chronic diseases, particularly in the context of Brazil's rising obesity rates.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Women over 18 years of age
* Diagnosis of obesity (body mass index \[BMI \>30 kg/m²\])
* Diagnosis of non-insulin-dependent type II diabetes

Exclusion Criteria:

* Use of dietary supplements or corticosteroid use in the last 3 months
* Diagnosis of insulin dependent diabetes
* Diagnosis of cancer
* Diagnosis of heart failure
* Diagnosis of kidney diseases
* Diagnosis of liver diseases
* Diagnosis of lung diseases
* Diagnosis ofneurological diseases
* Diagnosis of allergy to any component of the high saturated fat meal or walnuts

Where it's running

• São Paulo State University (UNESP), Medical School, Botucatu
  Botucatu, São Paulo, Brazil Recruiting

Study contacts

• Principal investigator: Marcos M Ferreira, PhD — FMB/Unesp
• Study coordinator: Raquel S Ballarin, M.D.
• Email: raquel.ballarin@unesp.br
• Phone: 5514997864806

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Switching to Zenagamtide From Tirzepatide in Adults With Overweight or Obesity With or Without Type 2 Diabetes

  This study tests whether adults who are overweight or have obesity (with or without type 2 diabetes) can switch from tirzepatide to a new treatment called zenagamtide to find a tolerable dose.

  Recruiting at 2 sites Phase 1 Novo Nordisk A/S · Glendale, California and 1 other locations · NCT07868354

• Switching to Zenagamtide from Semaglutide in adults with overweight or obesity, with or without type 2 diabetes

  This study tests whether adults who are already taking semaglutide can successfully switch to zenagamtide at different doses to see which dose works best.

  Recruiting at 2 sites Phase 1 Novo Nordisk A/S · Glendale, California and 1 other locations · NCT07855133

• Using Multimodal Ultrasound to Check Muscle Mass in Metabolic Disease Patients

  This study tests whether a multimodal ultrasound approach can accurately measure muscle mass in people with metabolic syndrome, obesity, sarcopenia, or type 2 diabetes.

  Recruiting Zhangzhou Municipal Hospital · Zhangzhou, Fujian · NCT07836088

• GUB-UCN2 in healthy, obese, and T2D adults: a first-in-human safety and pharmacology study

  This study tests GUB-UCN2 to see if it is safe and tolerable and how it behaves in the body in healthy adults, people with obesity, and people with obesity with or without type 2 diabetes.

  Recruiting Phase 1/2 Gubra A/S · Neuss · NCT07702890

• Two doses of CagriSema plus one dose of Semaglutide for weight loss in obesity with or without type 2 diabetes

  This study tests whether two doses of CagriSema, plus a dose of Semaglutide, help adults with obesity (with or without type 2 diabetes) lose weight.

  Recruiting Phase 3 Novo Nordisk A/S · Birmingham, Alabama and 302 other locations · NCT07564414

• Semaglutide's effects on heart and muscle mass

  This project will use MRI scans and strength tests over 12 months to see if semaglutide changes body and heart muscle in adults starting the medication.

  Recruiting University of Alberta · Edmonton, Alberta · NCT07272837

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.